OTCToolbox/PLG Conference: Capitalising on Change Through Innovation and Business Development

01.03.2018 | London(UK)
PLG - Pharmaceutical Licensing Group
Due to the new MDR regulation, medical devices face significant changes. At the OTCToolbox/PLG Conference, in London Dr. Guido Middeler (Diapharm) and Michael Sander (SanderStrothmann) explain how to "Work With the New Medical Device Rules". The conference and networking event, now in its third year, focuses exclusively on business development and innovation in the consumer healthcare/OTC market.

Capitalising on change through OTC innovation and business development is the theme of the 3rd OTCToolbox/PLG OTC Conference and Networking Event, which will feature a Keynote Presentation by Uta Kemmerich-Keil, President and Chief Executive Officer of Merck Consumer Health, as well as presentations by Pfizer Consumer Healthcare, Nelsons and Glenmark.

Jointly organised by www.OTCToolbox.com and the Pharmaceutical Licensing Group (PLG), the two-day international features a programme of highly-respected speakers from the consumer healthcare/OTC industry, covering a wide range of topics:

  • The Rise of the Consumer in Health
    (Uta Kemmerich-Keil, President and CEO, Merck Consumer Health)
  • The Main Drivers of Growth
    (Andy Tisman, Global Senior Principal Consumer Health, QuintilesIMS)
  • Changing Innovation
    (Tim Brady, Director Business Development and International Sales, Thornton & Ross)
  • Working With the New Medical Device Rules
    (Guido Middeler, Head of Medical Devices Services & Partner, Diapharm;
    Michael Sander CEO of SanderStrothmann and Sastomed)
  • Case Study: How Insights Shape Innovation in Natural Healthcare
    (Aftab Aslam, Global Head of Strategic Insights, Nelsons)
  • Succeeding with Prescription-to-OTC Switches: The Commercial Perspective
    (Mark Bowden, VP Regulatory Affairs, Pfizer Consumer Healthcare)
  • The Regulatory Roadmap to Success
    (James Hall, Director, Jenson R+;
    Harriet Scorer, Medical Affairs Specialist, Scorer Health)
  • The Importance of Changing Behaviour
    (Alison Carr, Clinical Director, Hamell)
  • Switching in Action
    (Natalie Gauld, Natalie Gauld Ltd)
  • Case Study: Maloff Protect Switch
    (Achin Gupta, Executive VP & Business Head Europe, Glenmark Pharmaceuticals Europe)
  • Private Equity Interest and Other Trends
    (Deborah Wilkes, Founder & Publisher, OTCToolbox)
  • New Retail Opportunities
    (speaker to be confirmed)

Further information:





Sprechen Sie uns an!

Unser Servicetelefon +49 251 609350 
+43 1 5321606 

Unsere E-Mail info@diapharm.com